CYP2C19 Genotype-Guided Antiplatelet Therapy and 30-Day Outcomes After Percutaneous Coronary Intervention

被引：9
|
作者：
Williams, Alexis K. [1 ]
Klein, Melissa D. [2 ]
Martin, Jesse [1 ]
Weck, Karen E. [4 ]
Rossi, Joseph S. [2 ,3 ]
Stouffer, George A. [2 ,3 ]
Lee, Craig R. [1 ,3 ]
机构：
[1] Univ N Carolina, Eshelman Sch Pharm, Div Pharmacotherapy & Expt Therapeut, Chapel Hill, NC USA
[2] Univ N Carolina, Sch Med, Div Cardiol, Chapel Hill, NC USA
[3] Univ N Carolina, McAllister Heart Inst, Chapel Hill, NC USA
[4] Univ N Carolina, Sch Med, Dept Pathol & Lab Med, Chapel Hill, NC USA
来源：
CIRCULATION-GENOMIC AND PRECISION MEDICINE | 2019年 / 12卷 / 02期
关键词：
cardiovascular diseases; clopidogrel; pharmacogenetics; precision medicine; IMPLEMENTATION;
D O I：
10.1161/CIRCGEN.119.002441
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：97 / 99
页数：3
相关论文
共 50 条
  • [31] Evaluation of race and ethnicity disparities in outcome studies of CYP2C19 genotype-guided antiplatelet therapy
    Nguyen, Anh B.
    Cavallari, Larisa H.
    Rossi, Joseph S.
    Stouffer, George A.
    Lee, Craig R.
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [32] The efficacy and safety of CYP2C19 genotype-guided antiplatelet therapy compared with conventional antiplatelet therapy in patients with acute coronary syndrome or undergoing percutaneous coronary intervention: A meta-analysis of randomized controlled trials
    Lyu, Si-Qi
    Yang, Yan-Min
    Zhu, Jun
    Wang, Juan
    Wu, Shuang
    Zhang, Han
    Shao, Xing-Hui
    Ren, Jia-Meng
    PLATELETS, 2020, 31 (08) : 971 - 980
  • [33] PERSONALISED ANTIPLATELET THERAPY ACCORDING TO CYP2C19 GENOTYPE AFTER PERCUTANEOUS CORONARY INTERVENTION IN CHINESE POPULATION: A RANDOMISED CONTROL TRIAL
    Xie, Xiang
    Ma, Yi-Tong
    Yang, Yi-Ning
    Ma, Yi-Tong
    HEART, 2012, 98 : E159 - E160
  • [34] Comparison of Two Point-of-Care CYP2C19 Genotyping Assays for Genotype-Guided Antiplatelet Therapy
    Zhou, Yaolin
    Armstead, Alicia R.
    Coshatt, Gina M.
    Limdi, Nita A.
    Harada, Shuko
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2017, 47 (06): : 738 - 743
  • [35] MULTI-SITE INVESTIGATION OF STRATEGIES FOR THE IMPLEMENTATION OF CYP2C19 GENOTYPE-GUIDED ANTIPLATELET THERAPY.
    Empey, P. E.
    Stevenson, J. M.
    Tuteja, S.
    Weitzel, K. W.
    Angiolillo, D. J.
    Beitelshees, A. L.
    Coons, J. C.
    Duarte, J. D.
    Franchi, F.
    Jeng, L. J.
    Johnson, J. A.
    Kreutz, R. P.
    Limdi, N. A.
    Maloney, K. A.
    Obeng, A. Owusu
    Peterson, J. F.
    Petry, N.
    Pratt, V. M.
    Rollini, F.
    Scott, S. A.
    Skaar, T. C.
    Vesely, M. R.
    Stouffer, G. A.
    Wilke, R. A.
    Cavallari, L. H.
    Lee, C. R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 : S31 - S32
  • [36] Clinical implementation of rapid CYP2C19 genotyping to guide antiplatelet therapy after percutaneous coronary intervention
    Larisa H. Cavallari
    Francesco Franchi
    Fabiana Rollini
    Latonya Been
    Andrea Rivas
    Malhar Agarwal
    D. Max Smith
    Kimberly Newsom
    Yan Gong
    Amanda R. Elsey
    Petr Starostik
    Julie A. Johnson
    Dominick J. Angiolillo
    Journal of Translational Medicine, 16
  • [37] Implementation and evaluation of a CYP2C19 genotype-guided antiplatelet therapy algorithm in high-risk coronary artery disease patients
    Lee, John Andrew
    Lee, Craig R.
    Reed, Brent N.
    Plitt, David C.
    Polasek, Melissa J.
    Howell, Lucius A.
    Cicci, Jonathan D.
    Tasca, Kristen E.
    Weck, Karen E.
    Rossi, Joseph S.
    Stouffer, George A.
    PHARMACOGENOMICS, 2015, 16 (04) : 303 - 313
  • [38] Clinical implementation of rapid CYP2C19 genotyping to guide antiplatelet therapy after percutaneous coronary intervention
    Cavallari, Larisa H.
    Franchi, Francesco
    Rollini, Fabiana
    Been, Latonya
    Rivas, Andrea
    Agarwal, Malhar
    Smith, D. Max
    Newsom, Kimberly
    Gong, Yan
    Elsey, Amanda R.
    Starostik, Petr
    Johnson, Julie A.
    Angiolillo, Dominick J.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2018, 16
  • [39] Impact of Implementing CYP2C19 Genotype-Guided Antiplatelet Therapy on P2Y12 Inhibitor Selection and Clinical Outcomes in Acute Coronary Syndrome Patients After Percutaneous Coronary Intervention: A Real-World Study in China
    Zhang, Yi
    Shi, Xiu-Jin
    Peng, Wen-Xing
    Han, Jia-Lun
    Lin, Bai-Di
    Zhang, Ru
    Zhang, Yun-Nan
    Yan, Jia-Lin
    Wei, Juan-Juan
    Wang, Yi-Fan
    Chen, Su-Wei
    Nan, Nan
    Fang, Zhen-Wei
    Zeng, Yong
    Lin, Yang
    FRONTIERS IN PHARMACOLOGY, 2021, 11
  • [40] Optimizing endovascular therapy for large vessel occlusion using CYP2C19 genotype-guided antiplatelet therapy: a case report
    Inui, Ryoma
    Ishiyama, Hiroyuki
    Abe, Soichiro
    Yoshimoto, Takeshi
    Fukumori, Junji
    Kushi, Yuji
    Imamura, Hirotoshi
    Kataoka, Hiroharu
    Ihara, Masafumi
    JOURNAL OF LABORATORY AND PRECISION MEDICINE, 2024, 9
12345